Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DxS appoints Ron Long non-executive director

This article was originally published in Clinica

Executive Summary

Manchester, UK-based companion diagnostics specialist DxS has made Ron Long non-executive director. Mr Long has had 40 years of experience in the pharmaceutical industry. He was most recently CEO for Amersham Pharmacia Biotech and vice-chairman of Amersham before retiring in 2001. He also worked with the Wellcome Foundation for over 22 years. Mr Long holds a number of other board positions including Medivir and Procognia Israel.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT041214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel